Table 3. Funding source of research across different categories of registration.
| Funded by pharmaceutical company (e.g. Bristol Myers Squibb) | Privately funded (e.g. Mayo Clinic) | Publicly funded (e.g. NIMH) | Combined funding | |
|---|---|---|---|---|
| 21 Unregistered articles a | 3 | 6 | 8 | 3 |
| 61 Retrospectively registered articles | 12 | 6 | 39 | 4 |
| 17 Articles with discrepancies between 'current POMs' in trial registry and article | 2 | 3 | 11 | 1 |
| 17 Articles marked 'discrepancy free' than had retrospective updates to POMs in trial registry | 12 | 1 | 3 | 1 |
| 26 Articles correctly registered with no POM discrepancies b | 17 | 1 | 7 | 1 |
aone study reported no source of funding,
bincludes 3 articles where we were unable to determine whether POMs retro updated in trial registry.